As of 2025-09-15, the EV/EBITDA ratio of VBI Vaccines Inc (VBIV) is -0.00. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. VBIV's latest enterprise value is 0.01 mil USD. VBIV's TTM EBITDA according to its financial statements is -45.59 mil USD. Dividing these 2 quantities gives us the above VBIV EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.1x - 17.4x | 15.7x |
| Forward P/E multiples | 22.6x - 32.7x | 27.8x |
| Fair Price | (6,740.45) - (5,174.43) | (6,475.47) |
| Upside | -10322379.3% - -7924181.9% | -9916600.6% |
| Date | EV/EBITDA |